Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALX
3101
Alexander's
ALX
$1.3B
| $539K | ﹤0.01% |
1,945
-310
| -14% | -$86.1K |
|
3102
PUT
McDonald's
MCD
$192B
| $538K | ﹤0.01% |
2,400
-294,600
| -99% | -$63M |
|
3103
Zymeworks
ZYME
$1.61B
| $537K | ﹤0.01% |
17,025
+15,508
| +1,022% | +$630K |
|
|
SMMF
3104
DELISTED
Summit Financial Group, Inc.
SMMF
| $536K | ﹤0.01% |
+20,166
| New | +$478K |
|
3105
First Mid Bancshares
FMBH
$1.39B
| $535K | ﹤0.01% |
12,196
+7,488
| +159% | +$282K |
|
3106
OrthoPediatrics
KIDS
$519M
| $534K | ﹤0.01% |
10,961
+4,829
| +79% | +$232K |
|
|
MIC
3107
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $534K | ﹤0.01% |
16,774
-8,548
| -34% | -$268K |
|
|
ZAGG
3108
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $534K | ﹤0.01% |
+124,568
| New | +$523K |
|
|
THR
3109
DELISTED
Thermon Group Holdings
THR
| $533K | ﹤0.01% |
27,377
+16,807
| +159% | +$307K |
|
|
TBNK
3110
DELISTED
Territorial Bancorp Inc.
TBNK
| $533K | ﹤0.01% |
20,159
+168
| +0.8% | +$4.36K |
|
|
AKTS
3111
DELISTED
Akoustis Technologies Inc
AKTS
| $533K | ﹤0.01% |
39,926
+17,191
| +76% | +$250K |
|
3112
Motorcar Parts of America
MPAA
$254M
| $532K | ﹤0.01% |
23,613
-13,416
| -36% | -$295K |
|
|
WWE
3113
DELISTED
World Wrestling Entertainment
WWE
| $532K | ﹤0.01% |
9,805
-6,027
| -38% | -$317K |
|
3114
York Water
YORW
$502M
| $531K | ﹤0.01% |
10,856
+4,172
| +62% | +$190K |
|
|
DESP
3115
DELISTED
Despegar.com
DESP
| $530K | ﹤0.01% |
38,900
+9,400
| +32% | +$120K |
|
3116
Five Point Holdings
FPH
$373M
| $530K | ﹤0.01% |
70,087
-1
| -0% | -$7 |
|
3117
CALL
Ulta Beauty
ULTA
$22B
| $526K | ﹤0.01% |
1,700
-19,600
| -92% | -$6.09M |
|
|
LGTY
3118
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $525K | ﹤0.01% |
25,351
+15,689
| +162% | +$314K |
|
|
AUD
3119
DELISTED
Audacy, Inc.
AUD
| $524K | ﹤0.01% |
99,940
+43,492
| +77% | +$211K |
|
3120
CALL
BioCryst Pharmaceuticals
BCRX
$2.28B
| $523K | ﹤0.01% |
+51,400
| New | +$530K |
|
3121
Meridian
MRBK
$234M
| $523K | ﹤0.01% |
40,220
+2,912
| +8% | +$34.2K |
|
3122
Great Southern Bancorp
GSBC
$874M
| $522K | ﹤0.01% |
9,202
+5,708
| +163% | +$305K |
|
3123
Resources Connection
RGP
$151M
| $522K | ﹤0.01% |
38,532
-5,581
| -13% | -$72K |
|
|
SCHW
3124
CALL
Charles Schwab
SCHW
$183B
| $521K | ﹤0.01% |
7,992
-314,560
| -98% | -$19.1M |
|
3125
Ascendis Pharma A/S
ASND
$16B
| $520K | ﹤0.01% |
4,039
-298
| -7% | -$45.3K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.